Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes

NCT04996264 is registered in ClinicalTrials.gov with Ophirex, Inc. as lead sponsor.

NCT NCT04996264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04996264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes
Lead sponsor
Ophirex, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2021
Completion date
June 8, 2023
Enrollment
95 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

envenomation, snake, envenoming, envenoming, snake, snakebites